Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Avalon GloboCare ( (ALBT) ) is now available.
On September 8, 2025, Avalon GloboCare Corp. announced an update to its investor presentation, highlighting its merger agreement with YOOV Group Holding Limited, an AI-as-a-Service platform. YOOV will become a wholly owned subsidiary of Avalon, with the merger expected to close in Q4 2025. This strategic move aims to enhance Avalon’s market position by integrating YOOV’s AI-driven business automation solutions, potentially optimizing operations and reducing costs for organizations. YOOV’s preliminary financial data for the fiscal year ending March 31, 2025, shows significant revenue and net income growth, although these figures are subject to final adjustments.
More about Avalon GloboCare
Avalon GloboCare Corp., founded in 2016 and headquartered in Freehold, New Jersey, is a developer of precision diagnostic consumer products and intellectual property in cellular therapy. The company is known for its KetoAir breathalyzer device and QTY protein design platform, developed in collaboration with MIT, and serves as an exclusive distributor in North America, South America, EU, and UK.
Average Trading Volume: 707,447
Technical Sentiment Signal: Sell
Current Market Cap: $8.9M
Learn more about ALBT stock on TipRanks’ Stock Analysis page.